CCNA2 and hepatocellular carcinoma: Bayard et al., indicated that some HCC subgroups exhibit cyclin activation through various mechanisms, including HBV and adeno-associated virus type 2 insertions and enhancer hijacking and recurrent CCNA2 fusions, defining a homogenous entity of aggressive HCC [35].